Literature DB >> 11530811

Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation.

Y W Lin1, K Hamahata, K Watanabe, S Adachi, Y Akiyama, M Kubota, T Nakahata.   

Abstract

We report a childhood case that showed the repeated appearance and disappearance of various kinds of cytogenetic abnormalities (CA) for 5.5 years after allogeneic bone marrow transplantation (BMT). The patient underwent allogeneic BMT from an HLA-matched unrelated donor during the second complete remission of acute lymphoblastic leukemia. The conditioning regimen for BMT consisted of etoposide, cyclophosphamide, anti-human thymocyte immunoglobulin, and total body irradiation. There were no leukemic relapses or secondary acute myeloid leukemia/myelodysplastic syndrome (AML/MDS) since the BMT. The CA occurred from residual recipient cells, which were damaged by chemotherapy or radiation prior to BMT. Although previous studies about post-BMT CA had reported the continuous emergence of identical clones, the present case showed the appearance of one different type of clone after another. Although the appearance of different types of CA may mean that these clones did not obtain any growth advantages, it may be a sign of genomic instability, which is probably a risk factor for the development of secondary AML/MDS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530811     DOI: 10.1007/BF02982555

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Authors:  G Socié; R E Curtis; H J Deeg; K A Sobocinski; A H Filipovich; L B Travis; K M Sullivan; P A Rowlings; D W Kingma; P M Banks; W D Travis; R P Witherspoon; J Sanders; E S Jaffe; M M Horowitz
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Chromosomal studies after bone marrow transplantation for leukaemia in children.

Authors:  H van den Berg; G Beverstock; J P Westerhof; J M Vossen
Journal:  Bone Marrow Transplant       Date:  1991-05       Impact factor: 5.483

3.  Spontaneous resolution of myelodysplastic cytogenetic abnormality developed during the treatment of leukemia.

Authors:  J Y Chu; J R Batanian; G B Gale; C H Dunphy; D E DeMello
Journal:  J Pediatr Hematol Oncol       Date:  1998 Jan-Feb       Impact factor: 1.289

Review 4.  Fanconi's anemia and malignancies.

Authors:  B P Alter
Journal:  Am J Hematol       Date:  1996-10       Impact factor: 10.047

5.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

6.  Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation.

Authors:  D W Milligan; M C Ruiz De Elvira; H J Kolb; A H Goldstone; G Meloni; A Z Rohatiner; P Colombat; N Schmitz
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

7.  Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.

Authors:  E Abruzzese; J E Radford; J S Miller; J J Vredenburgh; P N Rao; M J Pettenati; J M Cruz; J J Perry; S Amadori; D D Hurd
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

8.  Incidence of second malignant neoplasms in children: results of an international study.

Authors:  V Miké; A T Meadows; G J D'Angio
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

Review 9.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  Emergence of karyotypically unrelated clone in remission of de novo acute myeloblastic leukaemias.

Authors:  S Kudoh; H Asou; T Kyo; H Asaoku; H Dohy; M Eguchi; S Tashiro; K Tanaka; N Kamada
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

View more
  1 in total

1.  A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance.

Authors:  Yoshiko Nakagawa; Katsuhiro Miura; Tetsuo Yamazaki; Hikaru Ishizuka; Kazuhiro Takei; Umihiko Sawada; Yoshimasa Kura; Yoshihiro Hatta; Jin Takeuchi
Journal:  Int J Hematol       Date:  2010-02-13       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.